THE DEFINITIVE GUIDE TO PHARMACEUTICAL INGREDIENTS

“The existing scenario has uncovered some structural weaknesses while in the EU’s medicines offer chain and also a substantial dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides stated. She suggested that offer chain challenges be addressed within an EU pharmaceutical system envisioned to become re